138 related articles for article (PubMed ID: 11739983)
21. Danaparoid in the prevention of ischemic stroke in paroxysmal nocturnal hemoglobinuria.
Zyss J; Cakmak S; Derex L; Michallet M; Nighoghossian N
Cerebrovasc Dis; 2007; 23(5-6):462-3. PubMed ID: 17435387
[No Abstract] [Full Text] [Related]
22. Argatroban plus aspirin versus aspirin in acute ischemic stroke.
Chen L; Cao S; Yang J
Neurol Res; 2018 Oct; 40(10):862-867. PubMed ID: 30052164
[TBL] [Abstract][Full Text] [Related]
23. Comparing Cerebralcare Granule and aspirin for neurological dysfunction in acute stroke in real-life practice.
Zhao L; Liao L; Hu F
Psychogeriatrics; 2017 Jan; 17(1):3-8. PubMed ID: 26757022
[TBL] [Abstract][Full Text] [Related]
24. Frequency, risk factors, anatomy, and course of unilateral neglect in an acute stroke cohort.
Ringman JM; Saver JL; Woolson RF; Clarke WR; Adams HP
Neurology; 2004 Aug; 63(3):468-74. PubMed ID: 15304577
[TBL] [Abstract][Full Text] [Related]
25. Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.
Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Tsopozidi M; Savopoulos C; Hatzitolios AI
Cerebrovasc Dis; 2016; 41(5-6):226-32. PubMed ID: 26795462
[TBL] [Abstract][Full Text] [Related]
26. Combined use of Orgaran and Reopro during coronary angioplasty in patients unable to receive heparin.
Cantor WJ; Leblanc K; Garvey B; Watson KR; Rasymas A; Strauss BH
Catheter Cardiovasc Interv; 1999 Mar; 46(3):352-5. PubMed ID: 10348139
[TBL] [Abstract][Full Text] [Related]
27. Danaparoid: a review of its use in thromboembolic and coagulation disorders.
Ibbotson T; Perry CM
Drugs; 2002; 62(15):2283-314. PubMed ID: 12381232
[TBL] [Abstract][Full Text] [Related]
28. Atherosclerosis in Trial of Org 10172 in Acute Stroke Treatment Subtypes among Young and Middle-Aged Stroke Patients: The Norwegian Stroke in the Young Study.
Fromm A; Haaland ØA; Naess H; Thomassen L; Waje-Andreassen U
J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):825-30. PubMed ID: 26796053
[TBL] [Abstract][Full Text] [Related]
29. Circadian variation in ischemic stroke subtypes.
Chaturvedi S; Adams HP; Woolson RF
Stroke; 1999 Sep; 30(9):1792-5. PubMed ID: 10471425
[TBL] [Abstract][Full Text] [Related]
30. [Danaparoid sodium].
Kitazawa Y
Rinsho Byori; 2011 Feb; Suppl 147():164-6. PubMed ID: 21761765
[No Abstract] [Full Text] [Related]
31. [Use of Orgaran for extracorporeal circulation in a patient allergic to heparin].
Bretelle C; Leude E; Quilici J; Vaillant A
Presse Med; 1996 Nov; 25(37):1846-7. PubMed ID: 8991040
[No Abstract] [Full Text] [Related]
32. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
Counsell C; Sandercock P
Stroke; 2002 Jul; 33(7):1925-6. PubMed ID: 12105377
[No Abstract] [Full Text] [Related]
33. [Thromboembolytic complications. Alternative anticoagulation in HIT II].
Anaesthesist; 2000 Dec; 49(12):1077. PubMed ID: 11202083
[No Abstract] [Full Text] [Related]
34. The treatment and prevention of deep vein thrombosis in the preoperative management of patients who have neurologic diseases.
Farray D; Carman TL; Fernandez BB
Neurol Clin; 2004 May; 22(2):423-39. PubMed ID: 15062521
[TBL] [Abstract][Full Text] [Related]
35. Failure of Orgaran therapy in a patient with a previous heparin-induced thrombocytopenia syndrome.
Tardy/Poncet B; Mahul P; Beraud AM; Favre JP; Tardy B; Guyotat D
Br J Haematol; 1995 Aug; 90(4):969-70. PubMed ID: 7669684
[No Abstract] [Full Text] [Related]
36. Early recovery after cerebral ischemia risk of subsequent neurological deterioration.
Johnston SC; Leira EC; Hansen MD; Adams HP
Ann Neurol; 2003 Oct; 54(4):439-44. PubMed ID: 14520654
[TBL] [Abstract][Full Text] [Related]
37. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia].
Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734
[No Abstract] [Full Text] [Related]
38. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.
Lee YS; Bae HJ; Kang DW; Lee SH; Yu K; Park JM; Cho YJ; Hong KS; Kim DE; Kwon SU; Lee KB; Rha JH; Koo J; Han MG; Lee SJ; Lee JH; Jung SW; Lee BC; Kim JS
Cerebrovasc Dis; 2011; 32(1):65-71. PubMed ID: 21613787
[TBL] [Abstract][Full Text] [Related]
39. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
[TBL] [Abstract][Full Text] [Related]
40. [Value of orgaran in hemodialysis during heparin-induced thrombopenia].
Lamriben L; Tiberghien F; Delacour JL; Floriot C; Wagschal G; Daoudal P; Ory JP
Presse Med; 1996 Sep; 25(28):1303. PubMed ID: 8949796
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
